targeting btk in the treatment of patients with ms
Published 1 year ago • 298 plays • Length 32:35
Download video MP4
Download video MP3
Similar videos
-
48:33
btk inhibitors for ms: progress in the development of an emerging therapeutic approach
-
32:36
btk inhibition and the future of ms management
-
52:31
rationale, evidence, and practical potential for btk inhibitors in patient-centered ms care
-
22:36
progress with btk inhibitors: a journey through the mechanisms of covalent and noncovalent options
-
4:22
btk inhibitors in treating the spectrum of ms
-
1:16:09
learn more about btk inhibitors, smoldering ms and biomarkers - presented by aaron boster, md
-
22:04
bruton's tyrosine kinase inhibitors for multiple sclerosis explained by neurologist
-
2:11
btk and immune diseases | mod animation
-
20:35
hitting the mark with targeted therapy: braf, nras, ckit, etc...sullivan
-
50:02
exploring the rationale, results, and real-world clinical potential of btki in the management of ms
-
58:40
innovations and imaging in ms: examining the evidence, looking toward the future of btk inhibitors
-
40:44
harnessing the full potential of dmt mechanisms of action to improve ms outcomes
-
59:49
rebooting the btk inhibitor sequence in mcl
-
1:50
btk inhibitors for ms treatment: what do the recent trial readouts mean for the field?
-
13:45
ms and btk inhibitors
-
45:52
targeting alk - from discovery to frontline treatment
-
1:32
changes in gene expression in patients with wm after treatment with btk inhibitors
-
1:03:27
the rise of b-cell therapies in relapsing ms
-
45:35
btk inhibition as an ms treatment modality: where do we stand and where are we headed?
-
3:53
targeting btk in b-cell malignancies
-
1:36:53
new standards for cll care with btk inhibitors
-
1:25:33
customizing care in cll with btk inhibitors
Clip.africa.com - Privacy-policy